Skip to content

Efficacy and Safety of Sansoninto in Insomnia with Psychiatric Disorder: An Open-Label Study

Efficacy and Safety of Sansoninto in Insomnia with Psychiatric Disorder: An Open-Label Study - Sansoninto in Insomnia with Psychiatric Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014156
Enrollment
100
Registered
2014-06-04
Start date
2011-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnina with Psychiatric Disorder

Interventions

Sansouninto Treatment No treatment

Sponsors

Shimane University School of Medicine, Department of Psyvhiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects enrolled in the study were patients with psychiatric disorders, raging 27-80 years of age, with PSQI of greater than six. These patients 45 minutes or more failing asleep, slept less than six hours, and struggled with this issue continously for at least one month.

Exclusion criteria

Exclusion criteria: 1) within three months of the study there had been a major incident. 2) working the nightshift. 3) lack of time or tining conflicts.

Design outcomes

Primary

MeasureTime frame
PSQI

Secondary

MeasureTime frame
ISI, AIS, CGI-I

Countries

Japan

Contacts

Public ContactTsuyoshi Miyaoka

Shimane University School of Medicine Psychiatry

miyanyan@med.shimane-u.ac.jp0853-20-2262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026